Bedford, MA, United States of America

Sonja Komar-Panicucci


Average Co-Inventor Count = 13.0

ph-index = 4

Forward Citations = 153(Granted Patents)


Company Filing History:


Years Active: 1999-2004

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Sonja Komar-Panicucci: Innovator in Amyloid Research

Introduction

Sonja Komar-Panicucci is a notable inventor based in Bedford, MA (US). She has made significant contributions to the field of biomedical research, particularly in the area of amyloid peptide aggregation. With a total of 4 patents to her name, her work has the potential to impact the treatment of amyloidogenic diseases.

Latest Patents

One of her latest patents focuses on modulators of β-amyloid peptide aggregation comprising D-amino acids. This invention provides compounds that modulate natural β-amyloid peptide aggregation. The modulators consist of peptides that are entirely based on D-amino acids, typically comprising 3-5 D-amino acid residues. These residues include at least two independently selected from D-leucine, D-phenylalanine, and D-valine. A particularly preferred embodiment of this invention is a retro-inverso isomer of a β-amyloid peptide. The patent also discusses modifications at the amino-terminus and carboxy-terminus, with preferred modifying groups including cyclic and branched alkyl groups. Additionally, pharmaceutical compositions and diagnostic methods for amyloidogenic diseases are disclosed in her patents.

Career Highlights

Sonja Komar-Panicucci is currently associated with Praecis Pharmaceuticals, Inc., where she continues her innovative work in the field. Her research has garnered attention for its potential applications in treating diseases related to amyloid aggregation.

Collaborations

Throughout her career, she has collaborated with notable colleagues such as Mark A Findeis and Malcolm L Gefter. These collaborations have further enriched her research and contributed to her success as an inventor.

Conclusion

Sonja Komar-Panicucci is a pioneering inventor whose work in amyloid peptide research holds promise for advancing medical treatments. Her contributions to the field are significant and continue to inspire future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…